MedTrace Logo

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

NCT01888601 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 814

Last updated 2026-05-04

No results posted yet for this study

Summary

To study the NSCLC evolutionary genomic landscape between primary and metastatic sites and the dynamics of intratumour heterogeneity over time combined with detailed clinical, histopathological and cancer phenotypic annotation for each patient, in order to significantly improve the outcomes of NSCLC patients (e.g. reduce their chance of recurrence and improve survival).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Charles Swanton · Chief Investigator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2035-11-30
Completion
2035-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01888601 on ClinicalTrials.gov